Bone Biologics (BBLG) EBT (2016 - 2017)
Historic EBT for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to -$2.8 million.
- Bone Biologics' EBT rose 4105.69% to -$2.8 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$7.0 million, marking a year-over-year increase of 7275.54%. This contributed to the annual value of -$1.6 million for FY2021, which is 1173.86% up from last year.
- As of Q4 2017, Bone Biologics' EBT stood at -$2.8 million, which was up 4105.69% from -$2.4 million recorded in Q3 2017.
- In the past 5 years, Bone Biologics' EBT ranged from a high of $1.0 million in Q2 2017 and a low of -$12.3 million during Q1 2016